Trials / Not Yet Recruiting
Not Yet RecruitingNCT06402058
A Study Comparing DMSB01 and Rejuran® for Temporary Crow's Feet Lines Improvement
A Randomized, Subject and Evaluator Blinded, Matched Pairs, Pilot Study to Evaluate the Safety and Efficacy of DMSB01 According to the Number of Injections in Subjects With Crow's Feet Lines Compared to Control Device
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Samyang Biopharmaceuticals Corporation · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this Pilot Study is to verify the safety and efficacy of DMSB01 in the temporary improvement of Crow's Feet Lines
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | DMSB01 | Apply a maximum of 1.0 ml for each side of the Crow's Feet Lines using both the test device (DMSB01) and the control device (Rejuran®). |
| DEVICE | Rejuran® | Apply a maximum of 1.0 ml for each side of the Crow's Feet Lines using both the test device (DMSB01) and the control device (Rejuran®). |
Timeline
- Start date
- 2024-06-10
- Primary completion
- 2025-01-31
- Completion
- 2025-04-30
- First posted
- 2024-05-07
- Last updated
- 2024-05-13
Source: ClinicalTrials.gov record NCT06402058. Inclusion in this directory is not an endorsement.